← Leaderboards
Jane W. Newburger
Boston Children'S Hospital
$29,827,102
Attributed
$44,639,456
Total exposure
23
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$64,514,218 · 24
By mechanism
P50$23,272,170 · 3
U01$12,893,585 · 3
T32$11,621,522 · 1
R01$6,890,300 · 4
UM1$3,398,512 · 2
UG1$2,724,449 · 1
Top collaborators
- Christine E. Seidman16 shared
- Amy E Roberts12 shared
- John K Triedman12 shared
- William T Pu11 shared
- David E. Clapham7 shared
- Sarah D De Ferranti7 shared
- Michael John Rivkin4 shared
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- John K Triedman$3,858,283
- Bernhard Kuhn$9,305,831
- Amy E Roberts$2,726,639
- Meena Nathan$674,866
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodCongenital Heart DisorderClinical ResearchHuman SubjectImageChildCardiacBaseHeartMagnetic Resonance ImagingAffectResourcesHuman Therapy EvaluationHeart DiseasesPerformanceHeart /Lung BypassResearch PersonnelEnrollmentGeneticSuccessInfant Human (0-1 Year)Cardiovascular SystemOperative Surgical ProceduresLesion
Grant awards (123)
Research Methods in Pediatric Cardiovascular Disease$548,814
T32 · FY2025 · HL
Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital$497,813
UM1 · FY2025 · HL
Research Methods in Pediatric Cardiovascular Disease$575,656
T32 · FY2024 · HL
Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital$497,813
UM1 · FY2024 · HL
Genomic Effects on Right Ventricular Function, Clinical Features and Outcomes in CHD$479,711
U01 · FY2024 · HL · contact PI
Research Methods in Pediatric Cardiovascular Disease$703,838
T32 · FY2023 · HL
Genomic Effects on Right Ventricular Function, Clinical Features and Outcomes in CHD$489,500
U01 · FY2023 · HL · contact PI
Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital$389,207
UG1 · FY2023 · HL · contact PI
Research Methods in Pediatric Cardiovascular Disease$505,636
T32 · FY2022 · HL
Genomic Effects on Right Ventricular Function, Clinical Features and Outcomes in CHD$489,500
U01 · FY2022 · HL · contact PI
Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital$389,207
UG1 · FY2022 · HL · contact PI
Research Methods in Pediatric Cardiovascular Disease$654,752
T32 · FY2021 · HL
Genomic Effects on Right Ventricular Function, Clinical Features and Outcomes in CHD$489,500
U01 · FY2021 · HL · contact PI
Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital$389,207
UG1 · FY2021 · HL · contact PI
Genomic Effects on Right Ventricular Function, Clinical Features and Outcomes in CHD$508,750
U01 · FY2020 · HL · contact PI
Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital$389,207
UG1 · FY2020 · HL · contact PI
Research Methods in Pediatric Heart Disease$290,247
T32 · FY2020 · HL
Research Methods in Pediatric Heart Disease$599,045
T32 · FY2019 · HL
The Genomic Basis of Congenital Heart Disease and Neurodevelopmental Outcomes$476,803
UM1 · FY2019 · HL · contact PI
Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital$389,207
UG1 · FY2019 · HL · contact PI
Research Methods in Pediatric Heart Disease$576,823
T32 · FY2018 · HL
The Genomic Basis of Congenital Heart Disease and Neurodevelopmental Outcomes$476,803
UM1 · FY2018 · HL · contact PI
Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital$389,207
UG1 · FY2018 · HL · contact PI
Research Methods in Pediatric Heart Disease$558,994
T32 · FY2017 · HL
The Genomic Basis of Congenital Heart Disease and Neurodevelopmental Outcomes$476,803
UM1 · FY2017 · HL · contact PI
Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital$389,207
UG1 · FY2017 · HL · contact PI
Research Methods in Pediatric Heart Disease$2,160
T32 · FY2017 · HL
Research Methods in Pediatric Heart Disease$549,909
T32 · FY2016 · HL
The Genomic Basis of Congenital Heart Disease and Neurodevelopmental Outcomes$476,803
UM1 · FY2016 · HL · contact PI
Randomized Trial of Nonflouroscopic Technologies in Pediatric SVT Ablation$522,000
U10 · FY2015 · HL · contact PI
The Genomic Basis of Congenital Heart Disease and Neurodevelopmental Outcomes$495,674
UM1 · FY2015 · HL · contact PI
Research Methods in Pediatric Heart Disease$255,994
T32 · FY2015 · HL · contact PI
Copy Number Variants for Discovery of Congenital Heart Genes$793,208
U01 · FY2014 · HL
Research Methods in Pediatric Heart Disease$527,820
T32 · FY2014 · HL · contact PI
Randomized Trial of Nonflouroscopic Technologies in Pediatric SVT Ablation$522,000
U10 · FY2014 · HL · contact PI
Copy Number Variants for Discovery of Congenital Heart Genes$770,541
U01 · FY2013 · HL
Randomized Trial of Nonflouroscopic Technologies in Pediatric SVT Ablation$522,000
U10 · FY2013 · HL · contact PI
Research Methods in Pediatric Heart Disease$516,934
T32 · FY2013 · HL · contact PI
Copy Number Variants for Discovery of Congenital Heart Genes$809,394
U01 · FY2012 · HL · contact PI
Brain Structure and Function in Adolescents after the Fontan Operation$694,522
R01 · FY2012 · HL · contact PI
Randomized Trial of Nonflouroscopic Technologies in Pediatric SVT Ablation$522,000
U10 · FY2012 · HL · contact PI
Research Methods in Pediatric Heart Disease$516,934
T32 · FY2012 · HL · contact PI
Copy Number Variants for Discovery of Congenital Heart Genes$817,166
U01 · FY2011 · HL · contact PI
Brain Structure and Function in Adolescents after the Fontan Operation$755,140
R01 · FY2011 · HL · contact PI
Randomized Trial of Nonflouroscopic Technologies in Pediatric SVT Ablation$521,500
U10 · FY2011 · HL · contact PI
Research Methods in Pediatric Heart Disease$509,248
T32 · FY2011 · HL · contact PI
Copy Number Variants for Discovery of Congenital Heart Genes$802,998
U01 · FY2010 · HL · contact PI
Brain Structure and Function in Adolescents after the Fontan Operation$755,620
R01 · FY2010 · HL · contact PI
Research Methods in Pediatric Heart Disease$342,953
T32 · FY2010 · HL · contact PI
Randomized, placebo-controlled, double-blind trial of T3 in infant heart surgery$328,199
U01 · FY2010 · HL · contact PI
Brain Structure and Function in Adolescents after the Fontan Operation$725,664
R01 · FY2009 · HL · contact PI
Research Methods in Pediatric Heart Disease$473,820
T32 · FY2009 · HL · contact PI
Randomized, placebo-controlled, double-blind trial of T3 in infant heart surgery$328,199
U01 · FY2009 · HL · contact PI
Copy Number Variants for Discovery of Congenital Heart Genes$296,776
U01 · FY2009 · HL · contact PI
SSCOR in Pediatric Heart Development and Disease$3,836,294
P50 · FY2008 · HL · contact PI
Outcomes in Adolescence after Repair of d-TGA$602,543
R01 · FY2008 · HL · contact PI
Research Methods in Pediatric Heart Disease$470,010
T32 · FY2008 · HL · contact PI
Neurologic and Developmental Outcome in Teratology of Fallot$432,619
P50 · FY2008 · HL · contact PI
Randomized, placebo-controlled, double-blind trial of T3 in infant heart surgery$328,199
U01 · FY2008 · HL · contact PI
Core--Research Support and Statistics$323,116
P50 · FY2008 · HL · contact PI
SSCOR in Pediatric Heart Development and Disease$3,928,549
P50 · FY2007 · HL · contact PI
Outcomes in Adolescence after Repair of d-TGA$618,396
R01 · FY2007 · HL · contact PI
Research Methods in Pediatric Heart Disease$470,010
T32 · FY2007 · HL · contact PI
Neurologic and Developmental Outcome in Teratology of Fallot$464,080
P50 · FY2007 · HL · contact PI
Core--Research Support and Statistics$327,928
P50 · FY2007 · HL · contact PI
Randomized, placebo-controlled, double-blind trial of T3 in infant heart surgery$263,570
U01 · FY2007 · HL · contact PI
NEUROLOGICAL AND DEVELOPMENTAL OUTCOME IN TOF$6,513
M01 · FY2007 · RR · contact PI
OUTCOMES IN ADOLESCENCE AFTER REPAIR OF D-TGA$723
M01 · FY2007 · RR · contact PI
SSCOR in Pediatric Heart Development and Disease$4,048,278
P50 · FY2006 · HL · contact PI
Outcomes in Adolescence after Repair of d-TGA$645,239
R01 · FY2006 · HL · contact PI
Research Methods in Pediatric Heart Disease$395,218
T32 · FY2006 · HL · contact PI
Neurologic and Developmental Outcome in TOF$368,963
P50 · FY2006 · HL · contact PI
Randomized, placebo-controlled, double-blind trial of T3 in infant heart surgery$338,000
U01 · FY2006 · HL · contact PI
Core A--Research Support and Statistics$259,846
P50 · FY2006 · HL · contact PI
INFANT HEART SURGERY: CNS SEQUELAE OF HEMATOCRIT MANAGEMENT$5,169
M01 · FY2006 · RR · contact PI
SSCOR in Pediatric Heart Development and Disease$4,066,725
P50 · FY2005 · HL
Outcomes in Adolescence after Repair of d-TGA$642,856
R01 · FY2005 · HL
RESEARCH METHODS IN PEDIATRICS HEART DISEASE$415,556
T32 · FY2005 · HL
Neurologic and Developmental Outcome in TOF$359,835
P50 · FY2005 · HL
Core A--Research Support and Statistics$252,909
P50 · FY2005 · HL
Randomized Therapeutic Trials in Pediatric Heart Disease$71,371
U01 · FY2005 · HL
TRIAL OF TRI-IODOTHYRONINE IN INFANT HEART SURGERY$34,860
M01 · FY2005 · RR
TRIAL OF PULSE STERIOD THERAPY IN KAWASAKI DISEASE$23,241
M01 · FY2005 · RR
INFANT HEART SURGERY: CNS SEQUELAE OF HEMATOCRIT MANAGEMENT$15,251
M01 · FY2005 · RR
SSCOR in Pediatric Heart Development and Disease$3,994,916
P50 · FY2004 · HL
Randomized, placebo-controlled, double-blind trial of tri-iodothyronine in IHSrg$630,603
M01 · FY2004 · RR
Outcomes in Adolescence after Repair of d-TGA$607,127
R01 · FY2004 · HL
CLINICAL TRIAL OF HEMATOCRIT STRATEGY IN HEART SURGERY$492,411
U01 · FY2004 · HL
Randomized Therapeutic Trials in Pediatric Heart Disease$392,289
U01 · FY2004 · HL
Neurologic and Developmental Outcome in TOF$361,947
P50 · FY2004 · HL
Research Methods in Pediatrics Heart Disease$283,722
T32 · FY2004 · HL
Core A--Research Support and Statistics$246,165
P50 · FY2004 · HL
Trial of pulse steroid therapy in kawasaki disease$33,139
M01 · FY2004 · RR
Infant Heart Surgery: CNS Sequelae of Hematocrit Management$9,681
M01 · FY2004 · RR
Randomized Therapeutic Trials in Pediatric Heart Disease$637,321
U01 · FY2003 · HL
CLINICAL TRIAL OF HEMATOCRIT STRATEGY IN HEART SURGERY$589,621
U01 · FY2003 · HL
RESEARCH METHODS IN PEDIATRICS HEART DISEASE$446,996
T32 · FY2003 · HL
CLINICAL TRIAL OF HEMATOCRIT STRATEGY IN HEART SURGERY$595,956
U01 · FY2002 · HL
Randomized Therapeutic Trials in Pediatric Heart Disease$466,514
U01 · FY2002 · HL
RESEARCH METHODS IN PEDIATRICS HEART DISEASE$430,433
T32 · FY2002 · HL
CELL ADHESION &MIGRATION IN HUMAN VASCULAR INJURY$28,750
M01 · FY2002 · RR
INFANT HEART SURGERY--CNS SEQUELAE OF HEMATOCRIT MANAGEMENT$28,750
M01 · FY2002 · RR
INFANT HEART SURGERY--CNS SEQUELAE OF CIRCULATORY ARREST, 8 YEAR FOLLOW UP$28,750
M01 · FY2002 · RR
CY-1503 IN PREVENTION OF REPERFUSION INJURY IN INFANTS$0
M01 · FY2002 · RR
CLINICAL TRIAL OF HEMATOCRIT STRATEGY IN HEART SURGERY$556,787
U01 · FY2001 · HL
Randomized Therapeutic Trials in Pediatric Heart Disease$284,623
U01 · FY2001 · HL
GROWTH HORMONE FOR PEDIATRIC DILATED CARDIOMYOPATHY$132,952
R01 · FY2001 · HL
INFANT HEART SURGERY--CNS SEQUELAE OF CIRCULATORY ARREST$75,022
R01 · FY2001 · HL
INFANT HEART SURGERY--CNS SEQUELAE OF HEMATOCRIT MANAGEMENT$28,750
M01 · FY2001 · RR
INFANT HEART SURGERY--CNS SEQUELAE OF CIRCULATORY ARREST, 8 YEAR FOLLOW UP$28,750
M01 · FY2001 · RR
CELL ADHESION &MIGRATION IN HUMAN VASCULAR INJURY$28,750
M01 · FY2001 · RR
CELL ADHESION &MIGRATION IN HUMAN VASCULAR INJURY$28,750
M01 · FY2001 · RR
INFANT HEART SURGERY--CNS SEQUELAE OF HEMATOCRIT MANAGEMENT$28,750
M01 · FY2001 · RR
INFANT HEART SURGERY--CNS SEQUELAE OF CIRCULATORY ARREST, 8 YEAR FOLLOW UP$28,750
M01 · FY2001 · RR
CY-1503 IN PREVENTION OF REPERFUSION INJURY IN INFANTS$0
M01 · FY2001 · RR
CY-1503 IN PREVENTION OF REPERFUSION INJURY IN INFANTS$0
M01 · FY2001 · RR
CLINICAL TRIAL OF HEMATOCRIT STRATEGY IN HEART SURGERY$473,481
U01 · FY2000 · HL
INFANT HEART SURGERY--CNS SEQUELAE OF CIRCULATORY ARREST$392,371
R01 · FY2000 · HL
GROWTH HORMONE FOR PEDIATRIC DILATED CARDIOMYOPATHY$242,848
R01 · FY2000 · HL
INFANT HEART SURGERY--CNS SEQUELAE OF CIRCULATORY ARREST, 8 YEAR FOLLOW UP$28,750
M01 · FY2000 · RR
CELL ADHESION &MIGRATION IN HUMAN VASCULAR INJURY$28,750
M01 · FY2000 · RR
INFANT HEART SURGERY--CNS SEQUELAE OF HEMATOCRIT MANAGEMENT$28,750
M01 · FY2000 · RR
CY-1503 IN PREVENTION OF REPERFUSION INJURY IN INFANTS$0
M01 · FY2000 · RR